Tentamus Pharma
Private Company
Total funding raised: $10M
Overview
Tentamus Pharma, part of the global Tentamus Group, is a leading contract research organization (CRO) providing GMP-accredited analytical and quality control testing services. Founded in 2011 and headquartered in London, it leverages a network of seven UK laboratories staffed by over 300 professionals to serve the pharmaceuticals, medical devices, food & beverage, cosmetics, and water sectors. Its business model is purely service-based, generating revenue through a wide portfolio of accredited testing solutions, positioning it as a key partner for regulatory compliance and product safety. The company is privately held and operates in a stable, demand-driven market for quality assurance.
Technology Platform
Network of UKAS and GMP accredited laboratories utilizing advanced analytical techniques, including MALDI-TOF for microorganism identification, to provide comprehensive testing and quality assurance services.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
The market is fragmented and highly competitive, dominated by large global players like Eurofins, SGS, Bureau Veritas, and Intertek, as well as many specialized independent labs. Tentamus competes on deep sector expertise, personalized service, fast turnaround, and its position as a local, accredited partner within an international group.